Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Tamoxifen + Prometrium

1 clinical trial

2 indications

Indication
Breast Cancer
Indication
Hormone Receptor Positive Tumor
Clinical trial
A Window of Opportunity Study of Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Hormone Receptor-positive Breast Cancer.
Status: Recruiting, Estimated PCD: 2024-04-01